000 | 01917 a2200529 4500 | ||
---|---|---|---|
005 | 20250513040953.0 | ||
264 | 0 | _c19950509 | |
008 | 199505s 0 0 eng d | ||
022 | _a0022-2275 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBayon, Y | |
245 | 0 | 0 |
_aEffect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. _h[electronic resource] |
260 |
_bJournal of lipid research _cJan 1995 |
||
300 |
_a47-56 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aBridged Bicyclo Compounds, Heterocyclic |
650 | 0 | 4 |
_aCell Membrane _xchemistry |
650 | 0 | 4 |
_aDocosahexaenoic Acids _xblood |
650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
650 | 0 | 4 | _aEsterification |
650 | 0 | 4 | _aFatty Acids, Unsaturated |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrazines _xmetabolism |
650 | 0 | 4 | _aLinoleic Acid |
650 | 0 | 4 |
_aLinoleic Acids _xblood |
650 | 0 | 4 | _aMembrane Fluidity |
650 | 0 | 4 |
_aMembrane Lipids _xblood |
650 | 0 | 4 |
_aPhosphatidylcholines _xblood |
650 | 0 | 4 |
_aPhosphatidylethanolamines _xblood |
650 | 0 | 4 |
_aPhospholipids _xblood |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xmetabolism |
650 | 0 | 4 |
_aReceptors, Prostaglandin _xmetabolism |
650 | 0 | 4 |
_aReceptors, Thromboxane _xmetabolism |
650 | 0 | 4 | _aReceptors, Thromboxane A2, Prostaglandin H2 |
650 | 0 | 4 |
_aThromboxane A2 _xanalogs & derivatives |
700 | 1 | _aCroset, M | |
700 | 1 | _aDaveloose, D | |
700 | 1 | _aGuerbette, F | |
700 | 1 | _aChirouze, V | |
700 | 1 | _aViret, J | |
700 | 1 | _aKader, J C | |
700 | 1 | _aLagarde, M | |
773 | 0 |
_tJournal of lipid research _gvol. 36 _gno. 1 _gp. 47-56 |
|
999 |
_c7706350 _d7706350 |